Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Anstrom

Showing results (101-110 of 328) with videos related to

Pageof 33
Sort By:
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
European Journal of Heart Failure|June 25, 2026
Diuretic Resistance Risk and the Efficacy of Torsemide vs Furosemide: A Post-Hoc Analysis of the TRANSFORM-HF TrialNeil Keshvani, Amritesh Grewal, Syed K Rizvi, et al.
Journal of Diabetes and Its Complications|May 25, 2020
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT)Esteban Escolar, Francisco Ujueta, Hwasoon Kim, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 9, 2017
Long-Term Impact of an Electronic Health Record-Enabled, Team-Based, and Scalable Population Health Strategy Based on the Chronic Care ModelKensaku Kawamoto, Kevin J Anstrom, John B Anderson, et al.
Archives of Internal Medicine|January 13, 2006
Costs for heart failure with normal vs reduced ejection fractionLawrence Liao, James G Jollis, Kevin J Anstrom, et al.
JACC. Heart Failure|June 30, 2022
Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-InJustin M Vader, Michael M Givertz, Randall C Starling, et al.
Contemporary Clinical Trials|January 26, 2016
Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) StudyMona Fiuzat, Olaf Oldenberg, David J Whellan, et al.
Studies in Health Technology and Informatics|February 12, 2019
Death: The Simple Clinical Trial EndpointEric L Eisenstein, Kristi Prather, Stephen J Greene, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Clinical Cardiology|November 14, 2019
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trialJonathan W Cunningham, Jie-Lena Sun, Finnian R Mc Causland, et al.
Pageof 33

Showing results (101-110 of 328) with videos related to

Sort By:
Pageof 33
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
European Journal of Heart Failure|June 25, 2026
Diuretic Resistance Risk and the Efficacy of Torsemide vs Furosemide: A Post-Hoc Analysis of the TRANSFORM-HF TrialNeil Keshvani, Amritesh Grewal, Syed K Rizvi, et al.
Journal of Diabetes and Its Complications|May 25, 2020
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT)Esteban Escolar, Francisco Ujueta, Hwasoon Kim, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 9, 2017
Long-Term Impact of an Electronic Health Record-Enabled, Team-Based, and Scalable Population Health Strategy Based on the Chronic Care ModelKensaku Kawamoto, Kevin J Anstrom, John B Anderson, et al.
Archives of Internal Medicine|January 13, 2006
Costs for heart failure with normal vs reduced ejection fractionLawrence Liao, James G Jollis, Kevin J Anstrom, et al.
JACC. Heart Failure|June 30, 2022
Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-InJustin M Vader, Michael M Givertz, Randall C Starling, et al.
Contemporary Clinical Trials|January 26, 2016
Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) StudyMona Fiuzat, Olaf Oldenberg, David J Whellan, et al.
Studies in Health Technology and Informatics|February 12, 2019
Death: The Simple Clinical Trial EndpointEric L Eisenstein, Kristi Prather, Stephen J Greene, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Clinical Cardiology|November 14, 2019
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trialJonathan W Cunningham, Jie-Lena Sun, Finnian R Mc Causland, et al.
Pageof 33